Eyeworld

World view Filling a void in the spectrum of options for presbyopia correction I ntracorneal inlays are a recent addition to the U.S.-based ophthalmologist's toolkit for presbyopia solutions. While available internationally for several years, we've seen a refinement of this technology and advances in available options. Usage reflects the prelimi- nary adoption of this new category: According to the 2015 ASCRS Clinical Survey of members, 7% of international and 4% of U.S. surgeons routine- ly implant intracorneal inlays. These numbers are expected to grow significantly in the coming years. As discussed in this month's feature articles, there are significant advantages of inlay technology in presbyobes in addi- tion to improving unaided near vision. These include retaining functional distance vision and improving intermediate vision, as well as the ability to remove the inlay if needed. Maintaining functional distance vision in the inlay eye represents an important advantage over traditional monovision, which is commonly used to address presbyopia. Who is the ideal candidate for an intracorneal inlay? There are many factors to consider, such as patient expectations, near vision requirements, a crystalline lens that is not impairing vision, and of course, a healthy ocular surface. There is no "one size fits all" technology for patients seeking pres- byopia correction, and we must adapt to this new category with the same diligence as alternative options that have been available in years past. Another exciting potential use of inlay technology is in pseudophakic patients with monofocal intraocular lenses who desire improved unaided near vision. There is a growing demand for vision improvement in this population. Results from the 2015 ASCRS Clinical Survey show that 31% of all cataract patients are targeted for monovision. These articles discuss not only the new options available, but also key considerations for determining treatment pathways and providing holistic care to ensure the best possible outcomes. Without a doubt, intracorneal in- lays will fill a void in the current spectrum of options, and with proper clini- cal and patient expectation management, will lead to excellent results. EW Steven Schallhorn, MD, refractive editor The official publication of the American Society of Cataract & Refractive Surgery A S C R S March 2016 Volume 21 • No. 3 Publisher Donald R. Long don@eyeworld.org Editorial Editor Amy Goldenberg amy@eyeworld.org Managing Editor Stacy Jablonski stacy@eyeworld.org Staff Writers Ellen Stodola ellen@eyeworld.org Liz Hillman liz@eyeworld.org Production Graphic Designer Julio Guerrero julio@eyeworld.org Graphic Design Assistant Susan Steury susan@eyeworld.org Production Manager Cathy Stern cathy@eyeworld.org Production Assistant Carly Peterson carly@eyeworld.org Contributing Writers Vanessa Caceres Bradenton, Fla. Michelle Dalton Reading, Pa. Rich Daly Arlington, Va. Lauren Lipuma Washington, D.C. Matt Young Malaysia Senior Contributing Writer Maxine Lipner Nyack, N.Y. Advertising Sales ASCRSMedia 4000 Legato Road Suite 700 Fairfax, VA 22033 703-591-2220 fax: 703-591-0614 eyeworld@eyeworld.org www.eyeworld.org Paul Zelin paul@eyeworld.org 703-383-5729 Classified Sales Cathy Stern cathy@eyeworld.org 703-383-5702 EyeWorld Special Projects and Events Jessica Donohoe jessica@eyeworld.org Shelly Dixon shelly@eyeworld.org ASCRS Publisher: EyeWorld (ISSN 1089-0084) is published monthly by ASCRS Ophthalmic Services Corp., 4000 Legato Road, Suite 700, Fairfax, VA 22033-4055; telephone: 703-591-2220; fax: 703-591-0614. Printed in the U.S. Editorial Offices: EyeWorld News Service, 4000 Legato Road, Suite 700, Fairfax, VA 22033-4055; toll-free: 800-451-1339, 703-591-2220; fax: 703-591-0614; email: eyeworld@eyeworld.org. Advertising Offices: ASCRSMedia, 4000 Legato Road, Suite 700, Fairfax, VA 22033-4055; toll-free: 800-451-1339, 703-591-2220; fax: 703-591-0614; email: eyeworld@eyeworld.org. Copyright 2016, ASCRS Ophthalmic Services Corp., 4000 Legato Road, Suite 700, Fairfax, VA 22033-4055. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. Letters to the editor and other unsolicited material are assumed intended for publication and are subject to editorial review and acceptance. Subscriptions: Requests should be addressed to the publisher. Annual subscription prices: Individual: 1 year, $120; 2 years, $220; 3 years, $320. Institutional: 1 year, $250; 2 years, $330; 3 years, $425. Foreign: 1 year, $240, 2 years $470, 3 years, $700. Back copies: Subject to availability. Contact the publisher. Cost per copy is $15; $30 foreign. All orders for individual or back copies must be accompanied by payment. Requests to reprint, use, or republish: Requests to reprint or use material published herein should be made in writing only to Cathy Stern, EyeWorld, 4000 Legato Road, Suite 700, Fairfax, VA 22033-4055; toll-free: 800-451-1339, 703-591-2220; fax: 703-591-0614; email: eyeworld@eyeworld.org. EyeWorld reprints: To order reprints of material published in EyeWorld, contact Cathy Stern, EyeWorld, 4000 Legato Road, Suite 700, Fairfax, VA 22033-4055; toll-free: 800-451-1339, 703-591-2220; fax: 703-591-0614; email: cathy@eyeworld.org or your salesperson. Change of address: Notice should be sent to the publisher six weeks in advance of effective date. Include old and new addresses and label from recent issue. The publisher cannot accept responsibility for undelivered copies. POSTMASTER: Send change of address to EyeWorld, 4000 Legato Road, Suite 700, Fairfax, VA 22033. Periodical postage paid at Fairfax, VA 22033 and at additional mailing offices. The ideas and opinions expressed in EyeWorld do not necessarily reflect those of the editors, publisher, or its advertisers. P U B L I S H I N G S T A F F REGISTER TODAY AnnualMeeting.ascrs.org

• Cover